4//SEC Filing
Androski Lindsay 4
Accession 0001104659-23-008597
CIK 0001035354other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:07 PM ET
Size
6.0 KB
Accession
0001104659-23-008597
Insider Transaction Report
Form 4
Androski Lindsay
Director
Transactions
- Award
Stock Options (Right to Buy)
2023-01-30+2,859→ 2,859 totalExercise: $4.00Exp: 2033-01-30→ Common Stock (2,859 underlying)
Footnotes (1)
- [F1]The stock option vests as to 50% of the underlying shares on the first anniversary of January 30, 2023, and the remaining 50% of the underlying shares will vest in twelve (12) equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001936604
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 4:07 PM ET
- Size
- 6.0 KB